0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Special Feature |

Image of the Month—Quiz Case FREE

John A. Stauffer, MD; Jillian M. Bray, MD; Raouf E. Nakhleh, MD; Steven P. Bowers, MD
[+] Author Affiliations

Author Affiliations: Departments of Surgery (Drs Stauffer, Bray, and Bowers) and Pathology (Dr Nakhleh), Mayo Clinic, Jacksonville, Florida.


SECTION EDITOR: CARL E. BREDENBERG, MD


Arch Surg. 2011;146(9):1099. doi:10.1001/archsurg.2011.224-a.
Text Size: A A A
Published online

A 79-year-old man was referred by his dermatologist for diffuse subcutaneous nodules that had been present for more than 1 year. These nodules were painful, ruborous, and erythematous and had overlying epithelial exfoliation (Figure 1). The patient noticed the nodules initially on only his lower extremities but at presentation noted them on his torso and upper extremities. Biopsy specimens of these lesions revealed superficial perivascular lymphocytic inflammation and interstitial dermatitis consistent with pancreatic panniculitis. His medical history was significant for hypertension, coronary artery disease, prostate cancer, melanoma, and arthritic joint pains. Family history included a brother with cancer of the pancreas. The physical examination was otherwise unrevealing.

Place holder to copy figure label and caption
Graphic Jump Location

Figure 1. Photograph of a lower extremity subcutaneous nodule.

Computed tomographic imaging of the abdomen revealed a 9-cm heterogenous mass arising from the tail of the pancreas (Figure 2). Laboratory investigation revealed a lipase level of 13 008 U/L (to convert to microkatals per liter, multiply by 0.0167) (reference range, 7-60 U/L), gastrin level of 32 pg/mL (to convert to picomoles per liter, multiply by 0.481) (reference range, 0-99 pg/mL), and glucagon level of 0.331 pg/mL (to convert to nanogram per liter, multiply by 1) (reference range, 0-0.08 pg/mL). Liver function test results and carcinoembryonic antigen and cancer antigen 19-9 levels were normal.

Place holder to copy figure label and caption
Graphic Jump Location

Figure 2. Computed tomographic image of the abdomen.

The patient underwent laparotomy, which demonstrated a large, well-circumscribed, solid mass in the tail of the pancreas measuring 9.0 × 7.5 × 6.5 cm. There was no evidence of surrounding organ involvement. The mass was removed in its entirety along with the spleen. Pathologic gross examination revealed a lobulated, focally necrotic–appearing mass. Microscopic examination showed cells arranged in a trabecular pattern with abundant basophilic cytoplasm and large nuclei with prominent nucleoli. Immunostaining was strongly positive for periodic acid–Schiff and trypsin and weakly positive for synaptophysin.

WHAT IS THE DIAGNOSIS?

A. Pancreatic adenocarcinoma

B. Pancreatitis

C. Acinar cell carcinoma

D. Glucagonoma

Figures

Place holder to copy figure label and caption
Graphic Jump Location

Figure 1. Photograph of a lower extremity subcutaneous nodule.

Place holder to copy figure label and caption
Graphic Jump Location

Figure 2. Computed tomographic image of the abdomen.

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections